Related Experiment Video
Updated: Mar 16, 2026
14:39
Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
Published on: November 4, 2010
32.6K
Montelukast, current indications and prospective future applications.
Naim Kittana1, Suhaib Hattab1, Azza Ziyadeh-Isleem1
1a Division of Pharmacology and Physiology, Department of Biomedical Sciences, Faculty of Medicine and Health Sciences , An-Najah National University , Nablus , Palestine.
Expert Review of Respiratory Medicine
|August 4, 2016
Summary
Montelukast effectively treats asthma and allergic rhinitis. Research explores its potential in other respiratory and non-respiratory conditions, with ongoing trials needed for expanded use.
Area of Science:
- Pharmacology
- Respiratory Medicine
- Clinical Trials
Background:
- Montelukast is a standard treatment for asthma, exercise-induced bronchospasm, and allergic rhinitis.
- Emerging research suggests potential therapeutic roles in other respiratory ailments.
- Preclinical studies investigate its effects on non-respiratory conditions.
Purpose of the Study:
- To review current clinical and preclinical evidence on montelukast's efficacy.
- To assess its established and potential therapeutic applications.
- To identify areas requiring further investigation.
Main Methods:
- Systematic review of randomized clinical trials and real-world studies.
- Inclusion of in-vivo animal model studies for non-respiratory conditions.
- Focus on articles published in PubMed-cited journals.
Main Results:
- Clinical data support montelukast as an add-on or alternative to inhaled corticosteroids for chronic asthma.
- Evidence for efficacy in conditions beyond current indications is limited.
- Animal studies suggest potential pharmacological actions in non-respiratory diseases.
Conclusions:
- Montelukast is a valuable option for managing chronic asthma.
- Further clinical trials are necessary to validate its use in new indications.
- Expanded research is needed to confirm its safety and effectiveness in non-respiratory conditions.
Related Concept Videos
01:19Antiasthma Drugs: Leukotriene Modifiers
2.2K
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
2.2K
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
2.2K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
2.2K
01:20Asthma: Pathogenesis and Management
1.6K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.6K
01:30Asthma-IV: Diagnostic and Management
3.3K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.3K
01:26Asthma-II: Pathophysiology and Classification
4.8K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.8K
01:30Asthma-IV: Nursing Management
4.0K
The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
First, in...
4.0K